Q2 2026 saw revenue decline and negative EBITDA, but order intake and backlog improved, driven by strong PEM demand and the launch of a new pressurized alkaline platform. Cash position remains solid, with no urgent funding needs, and strategic partnerships and EU funding support future growth.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.